Zusammenfassung
Aufgrund der komplexen und multifaktoriellen Pathogenese des Syndroms der Tumorkachexie sollten wirksame Behandlungsansätze sinnvollerweise kombiniert werden, wofür Kenneth Fearon das Konzept eines multimodalen Therapieansatzes geprägt hat. Hierfür spricht insbesondere auch, dass Studien mit einem einzigen Therapieansatz, z. B. mit alleiniger Ernährungsberatung oder einem einzigen pharmakologischen Agens, kaum positive Resultate hervorgebracht haben.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr Edinb Scotl 2017;36:11–48.
Baldwin C, Spiro A, Ahern R, et al. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2012;104:371–385.
Cerchietti LCA, Navigante AH, Peluffo GD, et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study. J Pain Symptom Manage 2004;27:85–95.
Cerchietti LCA, Navigante AH, Castro MA. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 2007;59:14–20.
Fearon KCH. Cancer cachexia: develo** multimodal therapy for a multidimensional problem. Eur J Cancer 2008;44:1124–1132.
Fredrix EW, Staal-van den Brekel AJ, Wouters EF. Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors. Cancer 1997;79:717–723.
Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002;20:567–573.
Jatoi A, Rowland K, Loprinzi CL, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004;22: 2469–2476.
Leach HJ, Danyluk JM, Nishimura KC, et al. Benefits of 24 versus 12 weeks of exercise and wellness programming for women undergoing treatment for breast cancer. Support. Care Cancer Off. J Multinatl Assoc Support Care Cancer 2016;24:4597–4606.
Macciò A, Madeddu C, Gramignano G, et al. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol 2012;124:417–425.
Maddocks M, Hopkinson J, Conibear J, et al. Practical multimodal care for cancer cachexia. Curr Opin Support Palliat Care 2016;10:298–305.
Madeddu C, Dessì M, Panzone F, et al. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clin Nutr 2012;31:176–182.
Mantovani G1, Macciò A, Madeddu C et al., Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia Oncologist 2010;15:200–211.
Rogers ES, MacLeod RD, Stewart J, et al. A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients–ACCeRT study. BMC Cancer 2011;11:493.
Staal-van den Brekel AJ, Schols AM, Dentener MA, et al. The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 1997;76:1630–1635.
Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 2016;17:519–31.
Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol 2005;23:8500–8511.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Medizin Verlag GmbH, München
About this chapter
Cite this chapter
Arends, J., Blum, D. (2017). Multimodale Therapie bei Tumorkachexie. In: Kachexie bei Tumorerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-89935-305-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-89935-305-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-89935-304-4
Online ISBN: 978-3-89935-305-1
eBook Packages: Medicine (German Language)